fashion -WSS

fashion

author：comprehensive 2025-09-30 00:35:10 - browse：57235

An Ozempic pen connects dots that make up the shape o a brain — coverage from STAT — ILLUSTRATION: CHRISTINE KAO/STAT; PHOTOS: ADOBE

Drugs like Ozempic and Wegovy — already game changers for diabetes and obesity — are being studied to treat an entirely different growing health problem: mental health illnesses, including depression and bipolar disorder.

Early data and anecdotes suggest that this class of GLP-1 drugs could help patients feel less depressed and anxious. The treatment may also fight the decline in cognitive and executive function that many people with mental health disorders experience, like worsening memory and losing the ability to focus and plan.

If further research yields positive results, it could drive even more demand for the highly popular GLP-1 treatments, which have increasingly been shown to help with problems across the body, such as heart and kidney complications. And especially if the cognitive benefits are proven out, the GLP-1 drugs would plug a critical gap in current treatments for depression, since most depression drugs help with mood, but close to none address cognitive symptoms that affect memory and attention.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Kenai launches with $82 million for Parkinson’s stem cell therapy

explore

WSS

Study links childhood stress with decline in older age

'Null' research findings aren't empty of meaning. Let's publish them

International team creates first chimeric human

'Null' research findings aren't empty of meaning. Let's publish them

'Null' research findings aren't empty of meaning. Let's publish them

In search for therapies for solid tumors, companies turn to claudin

leisure time

fashion

leisure time

Psychedelics group wrestles with new pharma identity

FDA does about

Novavax promises a turnaround & Lilly roils the obesity market

FogPharma raises $145 million in rare Series E round

New air purifier tech could be key to improving indoor air quality

Heart disease in astronauts blamed on cosmic radiation

23andMe had bad news about my health. I wish a person had delivered it

RaDonda Vaught to speak at CommonSpirit event on patient safety

Wildfire smoke exposes gaps in outdoor worker protections

Late stage cancers on the rise after pandemic delayed screenings

hotspot

RaDonda Vaught to speak at CommonSpirit event on patient safety

When waiting feels immoral: Empathy in the emergency department

Scientists unlock the key to scar

International team creates first chimeric human

Physicians aren't 'burning out.' They're suffering from moral injury

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

explore

Wikipedia

hotspot

hotspot